SAB Biotherapeutics IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 3.51 USD | 5,15 USD | 1,85 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 11,182 USD | 4 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 76.464.094 | 5,94 | 3,68 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name SAB Biotherapeutics Inc
Mitarbeiter 86
Handelsplatz NASDAQ
Ticker Symbol SABS
IPO Datum 2021-02-09
Adresse 777 W 41st St., Miami Beach, FL, United States, 33140
Webseite https://www.sab.bio
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Samuel J. Reich | CEO & Director |
| 2 | Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director |
| 3 | Ms. Lucy To | Executive VP & CFO |
| 4 | Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO |
| 5 | Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer |
| 6 | Ms. Cristi Barnett | Vice President of Investor Relations & Corporate Communications |
| 7 | Ms. Catherine DeRose | Vice President of Human Resources |
| 8 | Ms. Hua Wu Ph.D. | Senior Vice President of Product Development |
| 9 | Dr. Carlos N. Carillo M.Sc., Ph.D. | Senior Vice President of Regulatory Affairs |
| 10 | Ms. Angie Parizek | Senior Vice President of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 0,00% | 0,00 Mio. USD |
| 2 | Caligan Partners LP | 0,00% | 0,00 Mio. USD |
| 3 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 4 | COMMODORE CAPITAL LP | 0,00% | 0,00 Mio. USD |
| 5 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 7 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 8 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 9 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 10 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Spruce Street Capital LP | 0,00% | 0,00 Mio. USD |
| 12 | Sessa Capital, L.P | 0,00% | 0,00 Mio. USD |
| 13 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Ameriprise Financial Inc | 0,00% | 0,00 Mio. USD |
| 16 | Ensign Peak Advisors Inc | 0,00% | 0,00 Mio. USD |
| 17 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |
| 18 | Propel Bio Management LLC | 0,00% | 0,00 Mio. USD |
| 19 | Jefferies Financial Group Inc | 0,00% | 0,00 Mio. USD |
| 20 | Blackstone Inc | 0,00% | 0,00 Mio. USD |